Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Thats a good summary of what we can expect, But the way JC is approaching this he may well have something else up his sleeve. He has definately grabbed the bull by the horns , one thought , has he been give a remit by the BOD to get it up and running quickly and get it sold?????.
Oh i wish we had a CEO who delivered on what he says???, looks like we have one at last. The fact that he is delivering for me means the market may return in our favour and that the conditions NICE set may not hold much relevance . Word gets about amongst doctors and regions and its just a matter of time before it moves further a field.
We know the sp can move when it wants to , could FDA news or stroke test news be the catalyst we need for that to happen.
Guy .i thought he already had, it was NICE that cancelled from last December and then JC explained why . We know that a fund raise is on the cards , it would make a change if there were discussions on what outcomes we could get from FDA news?. Why was NICE news cancelled, we know under the new format they can put conditions on approvals, its a given they can reject the test, so what other things were they not sure that was within their remit, hopefully they were not allowed without consultation to give a full approval and that is what they will deliver. Wishful thinking possibly but a lot more positive than some of the negative drivel that gets posted.
At first Budd was implying we would just go down the normal application route , it was only later the De Novo route was later mentioned which is cheaper and quicker for the FDA . But like you mentioned in the US it is different whereas you then have to go out and "sell" the product/test as it does nt become regulatory and this is where JC s contacts come in . Can we get a deal that assists in FDA application AND help sell it to the market , or is that just wishful thinking?.
The £2m was quoted but that was before they knew what routes they could go down . The De Novo route is about $100,000 BUT we really needed full approval to be certain . If we look at £2m as a maximum figure and we get assistance then that would be good for starters .Its good now that we have a CEO who can cope with more than 1 thing at a time and the one thing which has been mentioned is we need to get to the self funding stage , realistically within the next 12-18 months. It may seem a long time but it is realistic given the hoops we may have to jump through .
It seems to imply they know what route they will go down and what applications are required and if they can get funding to help with this .POSSIBLY with a backer of some sort or partnership, just guessing but with the contacts JC has it is going to be interesting and hopefully find out this month.
The NHS at present dont have to buy, as there is no FULL approval , that does nt mean to say they cant or dont want to .
If we had full approval then FDA approval would almost be a given , but we dont as yet. NICE have stated it would revue in 3 years , thats not to say they wont if they receive the relevent data which we have no idea the quantity they are looking for.
Any whiff of FDA news and or backer would greatly increase the sp thus making funding that much easier , a vicious circle which JC seems to be working to .
That is the main objective atm, if we can keep on chugging then it buys us time until we can get products to sell , not the best way to run a company but going by the trades there is interest there which is a positive.
Christmas is usually a cashing in time , we have seen what can happen to the sp on news, the difference now compared to a couple of years ago is that it is not sustained and is sold off. The new CEO i feel will start to change that BUT we will need some constant news flow on sales to take it to another level and stay there. The potential is definately there and i feel this year it could be achieved . 50p plus is possible with some momentum but currently many buyers are looking for short term gains and looking to trade it rather than invest .
FDA
news on who might join/partner with us and if funding will be available and will we apply and what route?.
Stoke test ,
Update from NICE as to will they grant us full approval or conditional ?. We were told the delay has nothing to do with the test bur rather what they can actually do with EVA? .We know they can do conditional as they did that with AIHL and we also know they could decline approval , so were they unsure to give full approval ?.
Sales updates.
Any more updates from UK outlets as to take-ups /sales and also more info from overseas distributers?
Fundraising,
What route we will raise funds OO, II,s or other equities , how much , what for and at what price?
Now if we can get answers of some kind to all these points then we could well be in for a busy and interesting few months , JC seems to be able to deliver so far on what he has stated and i see no reason to doubt him yet , Fundingbeing the elephant in the list , but that has a chance of coming out in a slightly positive way.
Morning System, i feel more funding may be required until we get to self sufficiant sales but under JC i can see it being less rhan some think and sales coming sooner than we can hope for. The CEO seems to have the bit between his teeth and knows the right people to talk to so the next 6 months or so look to be very exciting and interesting , gla.